Tuesday, February 7, 2023


Biotechnology News Magazine


Leigh MacConell PhD Appointed Chief Development Officer of High Tide Therapeutics: To Lead the Company’s Global Clinical Development

Leigh MacConell, Ph.D. will lead the company’s global clinical development, regulatory and quality functions, and will focus on driving the advancement of the company’s pipeline.

Bharatt Chowrira, PureTech’s President and Chief of Business and Strategy, Added to Board of Directors Effective 2/1/21

Bharatt Chowrira, MD has served as PureTech’s President and Chief of Business and Strategy since March 2017 and will continue in that role as an executive director of the Company. Dr. Chowrira’s appointment is effective from February 1, 2021.

Michael J. Klag, MD, MPH Appointed to the Doctor Evidence Medical Strategy Advisory Board

January 27, 2021 Michael J. Klag, MD, MPH, from the Johns Hopkins Bloomberg School of Public Health joins the Medical Strategy Advisory Board, expanding its...

Viresh Patel Appointed Seven Bridges Senior Vice President of Marketing

Viresh Patel, Ph.D., is a proven life sciences industry executive and renowned genomics marketer.

John Tourlas Appointed President of Medicom’s North American Business Unit: Effective January 4

John Tourlas is a seasoned leader with 30 years of experience and extensive strategic and operational expertise in international business management.

Second Genome Announces New Appointments: Susannah Cantrell, Ph.D. and Preeti G. Lal, Ph.D. Take On New Leadership Roles

"I am delighted to welcome both Susannah and Preeti to the Second Genome executive team. Their vast experience in life sciences and leadership will be critical in driving Second Genome's strategy and pipeline as we evolve into a product development company," stated Karim Dabbagh, Ph.D., president, and chief executive officer.